Evaluation of Efficacy and Review of Side Effect Profile in Epilepsy Patients Treated with Extended-Release Levetiracetam
LEV ER was associated with a significant reduction in seizure frequency and demonstrated a favorable tolerability profile, particularly with respect to psychiatric adverse effects. Transitioning from LEV IR to LEV ER may offer clinically meaningful advantages in selected patient populations. Nevertheless, further prospective studies with larger cohorts are warranted to confirm these findings.
Authors
- Fulya Eren (ORCID: https://orcid.org/0000-0001-9787-7551)
- Günay Gül (ORCID: https://orcid.org/0000-0003-2485-1654)
- Zeynep Canan Özdemir (ORCID: https://orcid.org/0000-0002-9172-9627)
- Fatma Aybüke Çokkaçar
Institutions
- University of Health Science (KH)
- Taksim German Hospital (TR)
- Bakırköy Psychiatric Hospital (TR)
- Sağlık Bilimleri Üniversitesi (TR)
- University of Health Sciences Antigua (AG)
Publication Details
- Journal
- Pakistan Journal of Medical Sciences
- Published
- 2025-11-03
- DOI
- https://doi.org/10.12669/pjms.41.11.12553
- Primary Topic
- Epilepsy research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00